SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-063062
Filing Date
2023-11-13
Accepted
2023-11-13 16:42:06
Documents
12
Period of Report
2023-11-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K acet-20231107.htm   iXBRL 8-K 43061
  Complete submission text file 0000950170-23-063062.txt   163670

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20231107.xsd EX-101.SCH 2472
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20231107_pre.xml EX-101.PRE 10289
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20231107_lab.xml EX-101.LAB 14018
6 EXTRACTED XBRL INSTANCE DOCUMENT acet-20231107_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 231399559
SIC: 2834 Pharmaceutical Preparations